HKG:6127

4 stories mentioning HKG:6127Updated 13d ago

Every FINWIRES story that references HKG:6127, newest first.

Joinn Laboratories Attributes Recent Stock Surge to Robust Earnings Forecast; Hong Kong Shares Fall 7%

Joinn Laboratories (SHA:603127, HKG:6127) said its recent stock rally could have been triggered by its half-year earnings guidance, according to a Friday filing with the Shanghai bourse.The drug research company's closing price deviated by more than 20% across three straight trading sessions from July 14 to 16.Joinn Lab expects its attributable profit to surge 885% to 1,377% to between 600.1 million yuan and 900.2 million yuan for the first half.Shares fell 7% in Hong Kong during late afternoon trading, and closed 10% in Shanghai on Friday.

HKG:6127SHA:603127

Asia16d ago

Joinn Laboratories Forecasts Up to 1,377% Surge in H1 Profit

Joinn Laboratories (SHA:603127, HKG:6127) expects an attributable profit of between 600.1 million yuan and 900.2 million yuan for the first half of 2026, up 885% to 1,377% from 60.9 million yuan a year prior.Revenue is expected to increase 0% to 10.5% to between 668.6 million yuan and 739 million yuan from 668.6 million yuan in the year-ago period, according to a Tuesday Hong Kong bourse filing.The drug research company attributed the profit forecast to a rise in the market price, and organic growth and appreciation of biological assets, leading to positive changes in their fair value, as well as stable operating status from the company's laboratories.

HKG:6127SHA:603127

Asia91d ago

Joinn Laboratories Grants 1.4 Million Award Shares Under 2022 Scheme

Joinn Laboratories (SHA:603127, HKG:6127) granted a little over 1.4 million award shares to 12 participants under a 2022 share incentive scheme, according to a Thursday Hong Kong bourse filing.Of the total, 500,00 shares were granted to Chair Feng Yuxia, with the others being offered to directors and managers of the group.

HKG:6127SHA:603127

Asia91d ago

Joinn Laboratories' Profit Surges 480% in Q1

Joinn Laboratories (HKG:6127, SHA:603127) posted net profit attributable to shareholders of 238.4 million yuan for the first quarter, up 480% from 41.1 million yuan a year earlier, according to a Wednesday Hong Kong bourse filing.Hong Kong-listed shares of the drug research firm were down over 6% in Thursday's late-morning trade.Earnings per share came in at 0.32 yuan, up from 0.05 yuan a year earlier.Revenue increased 10% to 316.1 million yuan from 287.3 million yuan in the prior-year period.

HKG:6127SHA:603127

Track with the FINWIRES app suite

FolioX

Track HKG:6127 in your portfolio

WheelAI

Analyze HKG:6127 options with the wheel strategy

StockInsider

See market sentiment on HKG:6127